☆ 4.7 Article

Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces Off' time in Parkinson's disease:: A double-blind, randomized, multicenter clinical trial (6002-US-005)

ANNALS OF NEUROLOGY (2008)

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Adenosine A2A receptor antagonist treatment of Parkinson's disease

W Bara-Jimenez et al.

NEUROLOGY (2003)

Add to Collection
Article Clinical Neurology

Randomized trial of the adenosine A2A receptor antagonist istradefylline in advanced PD

RA Hauser et al.

NEUROLOGY (2003)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.